Skip to main content
Germantown Innovation Center

epigenomics

By February 20, 2017No Comments
Epigenomics

http://www.epigenomics.com/en/

Epigenomics is a molecular diagnostics company focused on developing innovative screening tests for cancer. Our lead product, Epi proColon, is the first and only FDA-approved blood-based test for colorectal cancer.  In the US today, 1 in 3, or 23 million eligible people, are not screened for colorectal cancer.  Epi proColon provides a convenient blood-based option to address this non-screened population.

Epigenomics

 

LinkedIn
Twitter
Facebook
YouTube

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.